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OBJECTIVES: Diagnosing Appendicitis is a difficult challenge for emergency de-
partments. Appendicitis has been the subject of numerous investigations, but a
diagnostic tool of quality and applicability in the clinical routine has not yet been
identified. We constructed a clinical predictive model for Appendicitis using a
Bayesian network, using a decision analysis approach. METHODS:We designed a
methodology for the construction of decision models to support the process of
clinical diagnosis, which was applied specifically to the diagnosis of Appendicitis.
The methodology starts with a multiple correspondence analysis (MCA) for the
selected variables with the highest power of discrimination, based on which an
initial Bayesian network is proposed. This network was refined with the support of
a group of medical experts in the diagnosis, to define the final structure of the
Bayesian network. Finally, the model is validated through cross-validation
method. For validation we used Sanabria, Bermudez, Dominguez and Serna’s
(2007) database, which consists of 349 patients with suspected Appendicitis.
RESULTS: The implementation of the methodology produced results in a Bayesian
network that included eleven variables associated to signs, symptoms and labora-
tory results. The results of the proposedmodel, with respect tomedical assessment
without specialized tools for diagnosis, showed significant improvements in accu-
racy, from 81% to 94%; in sensitivity, from 85% to 98%; and in specificity, from 76%
to 90%. CONCLUSIONS: The Bayesian network constructed based on the MCA im-
proved the accuracy of Appendicitis diagnosis in comparison to othermodels avail-
able in the literature, among which are the Alvarado score and the Fenÿo score.
Additionally, the constructed Bayesian network has characteristics that facilitate
its applicability in the clinical routine.
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OBJECTIVES: To evaluate the usability of an electronic patient-reported outcome
(ePRO) diary in accordancewith recommendations for usability testing in the ISPOR
ePROTask Force Report.METHODS: TheNighttime Symptoms of COPD Instrument
(NiSCI) and Early Morning Symptoms of COPD Instrument (EMSCI) were pro-
grammed into a handheld device (HTC HD2®). The device and instructions [Quick
Reference Guide (QRG)] were evaluated in two rounds of testing. Each round con-
sisted of user acceptance testing (UAT) by researchers, followed by usability assess-
ment by COPD patients. Patients were trained to use the device and completed the
diary five to seven days at home, followed by a qualitative interview in the clinic
about the device’s usability. Time and duration of diary completion were recorded
on the device each day. At the interview, participants also completed a Device
Usability Questionnaire and answered questions regarding their background and
technology proficiency. RESULTS: Mean age of the sample (N15) was 60 years,
(range 40–87); 60% were male. All participants were diagnosed with COPD and
experienced symptoms at night or earlymorning, per inclusion criteria. Nine (60%)
reported being “moderately technically proficient”. Feedback from the first round
(n5) informed the refinement of screen layout, skip patterns, and QRG, before a
second round of interviews. Results from the second round (n10) confirmed ‘pop-
up’ message wording, readability, screen clarity, and comprehension. Of 15 partic-
ipants, 66.7% found the device “very easy” to learn and 73.3% rated overall use “very
easy.” Participants averaged 3.5 minutes for diary completion; completion time
decreased over time. CONCLUSIONS: This usability study confirmed that COPD
patients found the electronic, HTC HD2®-based NiSCI and EMSCI patient-friendly,
easy to use, and suitable for daily assessment of COPD symptoms.
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OBJECTIVES: To develop a simulated “control” group to compare Phase 1 trial data
from acute kidney failure (AKF) patients receiving novel renal-replacement ther-
apy (RRT) with a Selective Cytopheretic Device (SCD), and to compare clinical out-
comes and economic impact of SCD treatment to hemodialysis.METHODS: Clini-
cians collected data on the first 35 patients treated with the SCD. To add a second
interventional trial arm, the developer needed a simulated control group (control)
for comparative purposes. Data from the literature and 2009 MEDPAR files were
utilized to develop a control with clinical characteristicsmatching those of the trial
population but undergoing hemodialysis. Critically, cohorts were matched on di-
agnosis, SOFA score,mechanical ventilation, sepsis, and RRT treatment. Secondary
sources contained mortality data, survivor RRT dependency, and resource con-
sumption units for the control – variables captured for trial patients. Unit resource
costs for trial patients were based on MedPAR data and the literature. SCD costs
were manufacturer-supplied. We computed relative resource cost impact for both
cohorts from imputed units and unit costs. RESULTS: Our methods yielded suffi-
cient information to compare clinical outcomes and budget impact of SCD treat-
ment relative to hemodialysis. SCD-treated patients showed 60-daymortality rates
of 31% versus control rates 50%. Savings from reduced ALOS in trial patients
exceeded incremental costs of SCD treatment. We estimated future payer budget
impact using USRDS (2010) treatment costs for survivors in both groups with con-
tinuing RRT needs progressing to ESRD care. Results showed cost avoidance of
$2.0M for 100 AKF patients. Confidence in the model was supported by sensitiv-
ities to ICU ALOS and survival rates, non-estimated variables for both cohorts. The
model withstood key variable manipulation of 20% before conclusions changed
directionally. CONCLUSIONS: A simulated control approach is a cost-effective
means for small manufacturers to conduct early hypothesis testing and build a
foundation for later-stage development.
SURGERY – Clinical Outcomes Studies
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OBJECTIVES: The objective of this study was to determine the impact of adverse
events common to opiate use upon post-operative length of stay. METHODS: The
study was based in Cardiff and the Vale of Glamorgan in 2004. All admissions
involving a surgical procedure, other than those specifically relating to the gastro-
intestinal system, were extracted and those for patients with a secondary diagno-
sis of either constipation (ICD-10 K59), nausea and vomiting (R11), pruritus (L29),
headache (R51), dizziness (R42) or fever of unknown origin (R50) were flagged.
These cases werematched by age (5 year age banded) and sex to controls admitted
with the same procedure (defined by three character OPCS-4 code). Length of stay
for cases versus controls was compared using the Wilcoxon rank signed test.
RESULTS: Of 116,309 hospital episodes, 58,025 included a surgical procedure. Of
these 285 included one of the diagnoses listed above of which 234 (82.1%) could be
matchedwith an age and sex control. Mean age of subjects was 53.7 (sd 23.5) and 96
(41.%) were male. Overall length of stay was greater for cases (median  11.0 days
[IQR 6.0-20.25] versus controls (5.0 days [1.0-14.0] p0.001. This was true for most
subgroups: constipation 14.5 days [7-23.25] versus 6 days [2-19] p 0.001; nausea
and vomiting 14 days [6-22.25] versus 7 days [1-19.25] p0.001; pruritus 5 days
[3-12] versus 1 days [1-3] p0.027; headache 13 days [6-39.5] versus 1.5 days [0-6.25]
p0.011 and fever 8 days [4.5-12.5] versus 1 days [0-8] p0.011. There was no
significant difference for dizziness 8 days [1.75-13.5] versus 2 days [0-10.5] p0.229.
CONCLUSIONS: This study demonstrates that adverse events commonly associ-
ated with opioid use have a significant impact on post-operative length of stay.
Reducing these events could have benefits both in terms of the well-being of the
individual patient and overall healthcare costs.
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OBJECTIVES: Demand for a primary TKA is increasing and projected to grow expo-
nentially by 2030. Comorbidities have been identified as a contributor to increased
postoperative length of the stay (LOS) of the patient in the hospital, a major con-
tributor to the cost of TKA. The purpose of the study is to assess the effect of
comorbidities [diabetes, hypertension, obesity (bmi 30 kg/m2), chronic back
pain(CBP), insomnia, cancer, osteoporosis], on patient LOS after elective TKA.
METHODS: Patients 40 years old with a primary unilateral TKA, excluding those
with a 2nd TKA surgery within the year, were retrospectively extracted from a
clinical orthopedic database between September 1, 2008 to November 30, 2010. LOS
and comorbidities were obtained by chart abstraction from the electronic medical
record. Unadjusted and adjusted odds ratios (OR) of having a LOS 3 days were
calculated for each comorbidity. Using logistic regression analysis, ORs were ad-
justed for age, gender, pre-operative physical/mental health and preoperative level
of physical activity. RESULTS:A total of 174 patientswith an average age of 63.8 (SD
10.2, 41-85) years were included in the study; 63% (110) were female and 56% (98)
were obese. 75% of the patient population was discharged in 3 days. Unadjusted
analysis identified those with diabetes, hypertension, obesity, CBP, cancer and
osteoporosis as being more likely to have a LOS 3 than those without these co-
morbidities. In adjustedORs, the likelihood of having a LOS3 dayswere 7.88 times
(95% confidence interval[CI]2.28-27.21) among patients with osteoporosis and
1.87 times (95% CI1.20-9.96) among patients with a history of cancer versus those
without these comorbidities. CONCLUSIONS: Few studies have focused on specific
comorbidities that influence LOS. We found that preoperative diagnosis of osteo-
porosis or cancer increased the LOS following elective TKA. Previous determinants,
age, gender, pre-operative level of physical activity, preoperative and physical
health were not influential.
PSU3
ANALYSIS OF BARIATRIC OUTCOMES LONGITUDINAL DATABASE (BOLD) TO
PREDICT PERCENT BMI LOSS AFTER BARIATRIC SURGERY
Benoit SC1, Francis DM2, Hunter TD3
1University of Cincinnati Metabolic Disease Institute, Cincinnati, OH, USA, 2Ethicon Endo-
Surgery, Inc., Cincinnati, OH, USA, 3S2 Statistical Solutions, Inc., Cincinnati, OH, USA
OBJECTIVES: The objective of this study was to utilize the BOLD database to ana-
lyze percent BMI loss after bariatric surgery. Of particular interest was the deter-
mination of predictors to help explain the large variation in bariatric surgery
success.METHODS: The dataset extracted for analysis consisted of patients age 21
or older having their first bariatric surgery (laparoscopic adjustable gastric band
(LAGB), Roux-en-y gastric bypass (RYGB), or vertical sleeve gastrectomy (VSG)) be-
tween January 1, 2007 and February 26, 2010, with pre-surgery BMI of at least 30, a
baseline visit and at least one postoperative visit. Subpopulations with postopera-
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tive visits between 9-15, 15-21, and 21-27 months after surgery were identified for
12-month, 18-month, and 24-month endpoints. All available data relating to the
procedure, demographics, comorbidities, and prior surgical history were consid-
ered as potential predictors of %BMI loss. Regressionmodels, usingmultiplemodel
selection procedures, were fitted at each endpoint. RESULTS: The population con-
sisted of 31,443 LAGB, 40,352 RYGB, and 2194 VSG patients, of whom 79% were
female, 79% were Caucasian, and the mean age was 46 years. Of the total 73,989
patients, 26,920 had a 12-month endpoint, 7245 had an 18-month endpoint, and
1774 had a 24-month endpoint. Regression models explained 37 to 55% of the
variance in %BMI loss, depending primarily on the endpoint, with the highest
percent variance explained at the 12-month endpoint and the lowest at the 24-
month endpoint. Model selection methods made little difference in model fit. The
type of bariatric surgery performed was the most significant predictor in all mod-
els. Other significant predictors in various models included key demographic vari-
ables and comorbidities, as well as baseline BMI. CONCLUSIONS: The data in the
BOLD registry are sufficiently robust to enable the evaluation of predictors of bari-
atric surgery success including surgery type, comorbidities, baseline BMI and key
demographic variables.
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OBJECTIVES: To explore the feasibility of using linked hospital discharge and vital
statistics death records to study the comparative effectiveness of repairs for un-
ruptured abdominal aortic aneurysm (AAA) using traditional open aortic repair
(OAR) and endovascular aortic repair (EVAR).METHODS: Linked hospital discharge
and vital statistics death records of the California Office of Statewide Health Plan-
ning andDevelopmentwere used for 2000-2007. Hospitalized patients for AAAwith
OAR and those with EVAR were identified. Demographic characteristics, comor-
bidities, the rates of complication, mortality, readmissions were compared be-
tween these two groups. Descriptive statistics, Kaplan-Meier survival analysis, and
propensity scores were used. RESULTS:We identified 8343 AAA patients with OAR
and 6221 AAA patients with EVAR between 2000Q3 and 2007. The yearly number of
OARs declined from 1,766 to 80, while EVARs increased from 676 to 1,389. Patients
receiving OAR were more acutely ill and likely to be admitted through ED than
those with EVAR (8.5% vs. 2.8%). Preliminary results indicated that the inpatient
mortality rate was higher for OAR than EVAR (4.68 vs. 0.96 per 100; P  0.001). The
30 day post-dischargemortality rateswithOARwas not significantly different from
EVAR (0.49 vs. 0.32 per 100; P  0.127). CONCLUSIONS: The information generated
from the linked discharge and death data will be useful in developing hypotheses,
describing patients and trends, and obtaining fast, preliminary indications of the
effectiveness and safety of alternative treatments. Although we found issues with
the data quality about which data users need to be vigilant, these concerns do not
negate the potential value of the data as an important adjunct and precursor to
more expensive clinical trials. The strength of this observational analysis derives
from the inclusion of all hospital stays for intact AAA as compared to the selected
samples that often comprise randomized clinical trials.
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PREVALENCE OF CARDIOVASCULAR RISK FACTORS AMONG PATIENTS
UNDERGOING ELECTIVE CORONARY ARTERY BYPASS SURGERY
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OBJECTIVES: Globally 80% cardiovascular disease deaths occurred in low andmid-
dle income countries with almost equal proportion inboth gender. Evidence shows
that people in low andmiddle income countries are more exposed to cardiovascu-
lar risk factors while less exposed to preventivemeasures. It may lead to long
course of management by either/ both medical and surgical techniques including
coronary artery bypass surgery, increasing the economic burden.In order to find
avenue for prevention, we aimed to measure the prevalence of cardiovascular risk
factors among patients undergoing elective CABG in Karachi, Pakistan.METHODS:
Information was collected through structured questionnaire and entered into Mi-
crosoft Access software. On the basis of research hypotheses, specific data chunk
was extracted and analyzed in SPSS 19. RESULTS: In this retrospective chart re-
view, 2073 patient undergoing elective CABG between January 2006 to June 2011
were included. Mean age of the patients was 54.859.7 years. Out of all, 14.7%
patients were females.Family history was present in 53%, 47.7% were smokers.
Conventional risk factors of overweight was 47.10%, obese was 14.7%,diabetes was
47.7%, hypertension was 69.50%, dyslipidemiawas 50.20%,renal failure was 9.2%
and prior MI was 46.7%. Outcomes includeoperative mortality of 0.3% while14.8%,
renal failure, 7% arrhythmias, 2.3% reoperation and 3.1% prolonged ventilation as
postoperative complications. CONCLUSIONS: There is a high prevalence among
patients undergoing elective CABG of coronary risk factors including dyslipidemia,
hypertension, diabetes and smoking.
SURGERY – Cost Studies
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OBJECTIVES: The objective of this analysis is to assess impact on hospital costs for
a patient using sugammadex for reversal of deep neuromuscular blockade com-
pared to no reversal agent.METHODS: An economic model reflecting resource use
and costs associated with neuromuscular block and its reversal, and residual
blockade, was constructed for the Swedish healthcare setting. Sugammadex was
compared to no reversal as other reversal agents are ineffective in reversing deep
block. Clinical trial data were used to estimate time savings relating to shortened
reversal in the operating room (OR). Costs of OR timewere derived from labor costs
for different types of OR staff. Resource use associated with clinical sequelae of
residual blockade (aspiration, hypoxemia, muscle weakness, upper airway ob-
struction) was estimated from the literature, where available. Unit costs were
taken from published pricelists of the state-owned pharmacy chain and, published
hospital price lists. RESULTS: If all OR staffmodeled (anesthetist, two surgeons and
two nurses) can be re-allocated to realize time savingswith shortened reversal, use
of Sugammadex compared to no reversal of deep neuromuscular blockade is esti-
mated to save 353 SEK per reversed patient. This corresponds to an increase in
drug costs of 1953 SEK, which is more than fully offset by a decrease in the costs of
OR staff time and clinical sequelae of residual blockade (-2306 SEK). In a worst case
scenario, if only the anesthetist, one surgeon and one nurse realize time savings,
costs would be increased (594 SEK) compared to no reversal. Results were sensitive
to OR staff costs and time savings. CONCLUSIONS: Sugammadex for reversal of
deep neuromuscular blockade can potentially lead to cost savings in the Swedish
health care setting. The degree to which costs may be saved depends upon which
OR staff are able to redeploy to other activities with shortened reversal.
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OBJECTIVES: This study was to estimate economic burden of obesity and to assess
the impact of bariatric surgery on health care costs and utilization in adults in
Alberta.METHODS:Multivariate regressionmodelswere developed to estimate the
impact of BMI on physician, outpatient and inpatient costs and visits. A pre-post
analysis over a 5-year period was conducted to compare the cost and visits before
and after surgery. Patients who received bariatric surgery in 2006 were identified
using the the Canadian Classification of Health Interventions (CCI) codes that cor-
respond to bariatric surgery. Total physician, inpatient and outpatient costs and
visits were calculated across all patients, over a period of two years before and two
years after surgery. Health utilization data from Alberta provincial health admin-
istrative databases were linked with epidemiologic and demographic data con-
tained in Canadian Community Health Survey (CCHS). RESULTS:When combining
physician and outpatient costs, the mean estimate per obese resident was $696,
following by $545 for overweight, $523 for underweight, and $480 for normalweight
residents. Compared to normal weight, obesity, overweight and underweight were
associated with increases of $217, $65 and $44, respectively. There were 217 bari-
atric surgery recipients in 2006. Health care costs and utilization two years pre-
surgery were greater than two years post-surgery. The marginal change in health
care costs and utilization between 2004 and 2005, however, was positive, indicating
an increase prior to surgery. In contrast, the marginal change in health care costs
and utilization was negative, indicating a decrease post-surgery. The estimate of
total physician and hospital costs associated with bariatric surgery was $12,175.79
(SE: $586.75). CONCLUSIONS: Obesity placed a large economic burden on health
care system. The bariatric surgery may alter the upward trajectory of health utili-
zation for severely obese patients. Further research including longer follow-up
period is necessary to confirm the impact of bariatric surgery.
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OBJECTIVES: Incidence of total knee arthroplasties (TKAs) increased from 31.2 to
220.9 per 100,000 person-years in the US from 1971-1976 to 2005-2008. Muscle at-
rophy/weakness pre- or post-TKA surgery is associated with poor postoperative
function. This review assessed disease burden andmedical needs in older patients
with TKA and muscle atrophy/weakness in US, Canada, Australia, and five major
countries in Europe.METHODS: Using keywords related to muscle atrophy/weak-
ness and TKA, we systematically searched English-language, MEDLINE- or EM-
BASE-indexed literature published fromMay 2001 to May 2011 andmaterials avail-
able from governmental or professional organizations. Selected articles focused on
epidemiologic, economic, humanistic, and treatment burden of muscle atrophy/
weakness (defined as evaluations of muscle atrophy, strength, or performance) in
adults ages 50 with TKA. Excluded articles were molecular and genetic studies,
case reports, and evaluations of muscle atrophy/weakness in 20 patients.
RESULTS: Eighty-three articleswere included. Strength and function improve from
preoperative baseline starting 3-4 months postoperatively but remain impaired
compared with healthy controls. Postoperative physical therapy (PT), exercise, or
electrical muscle stimulation improve strength and performance and accelerate
recovery; however, operated limbs may never regain strength to match healthy
controls or non-operated limbs. Preoperative exercise and education (Canada) or
inpatient aquatic PT (Australia) do not reduce hospital length of stay versus usual
care. Guidelines and real-world treatment pattern studies do not address optimal
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